Other Species / Isoforms
  TEC (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T5-p
___MNFNtILEEILI
0 1
TEC (human) ___MNFNtILEEILI T5-p
TEC (mouse) ___MNFNTILEEILI T5
TEC (rat) gap -
K51-ub
RAEKKYRkGFIDVSK
0 1
TEC (human) RAEKKYRkGFIDVSK K51-ub
TEC (mouse) RAEKKYRKGVIDISK K51
TEC (rat) gap -
T88-p
QVVHDANtLyIFAPS
0 1
TEC (human) QVVHDANtLyIFAPS T88-p
TEC (mouse) QVVHDANTLYIFAPS T88
TEC (rat) SRCSDANTLYIFAPS T12
Y90-p
VHDANtLyIFAPSPQ
0 1
TEC (human) VHDANtLyIFAPSPQ Y90-p
TEC (mouse) VHDANTLYIFAPSPQ Y90
TEC (rat) CSDANTLYIFAPSPQ Y14
Y120-p
NNNIMIKyHPKFWTD
0 1
TEC (human) NNNIMIKyHPKFWTD Y120-p
TEC (mouse) NNNIMIKYHPKFWAD Y120
TEC (rat) NNNIMIKYHPKFWAD Y44
S129-p
PKFWTDGsyQCCRQT
0 1
TEC (human) PKFWTDGsyQCCRQT S129-p
TEC (mouse) PKFWADGSYQCCRQT S129
TEC (rat) PKFWADGSYQCCRQT S53
Y130-p
KFWTDGsyQCCRQTE
0 1
TEC (human) KFWTDGsyQCCRQTE Y130-p
TEC (mouse) KFWADGSYQCCRQTE Y130
TEC (rat) KFWADGSYQCCRQTE Y54
K155-ub
LFESSIRkALPPAPE
0 5
TEC (human) LFESSIRkALPPAPE K155-ub
TEC (mouse) LFESSIRKTLPPAPE K155
TEC (rat) LFESSIRKTLPPAPE K79
Y188-p
EEIVVAMyDFQAAEG
1 1
TEC (human) EEIVVAMyDFQAAEG Y188-p
TEC (mouse) EEIVVAMYDFQATEA Y187
TEC (rat) EEIVVAMYDFQATEA Y110
Y206-p
RLERGQEyLILEKND
Upstream
1 1
Kinase, in vitro:
  • Btk (human)
  • ITK (human)
  • TEC (human)
TEC (human) RLERGQEyLILEKND Y206-p
TEC (mouse) RLERGQEYIILEKND Y205
TEC (rat) RLERGQKYIILEKND Y128
Y223-p
WWRARDKyGNEGyIP
0 1
TEC (human) WWRARDKyGNEGyIP Y223-p
TEC (mouse) WWRARDKYGSEGYIP Y222
TEC (rat) RWRARDKYGSEGYIP Y145
Y228-p
DKyGNEGyIPSNyVT
0 6
TEC (human) DKyGNEGyIPSNyVT Y228-p
TEC (mouse) DKYGSEGYIPSNYVT Y227
TEC (rat) DKYGSEGYIPSNYVT Y150
Y233-p
EGyIPSNyVTGKKSN
0 3
TEC (human) EGyIPSNyVTGKKSN Y233-p
TEC (mouse) EGYIPSNYVTGKKSN Y232
TEC (rat) EGYIPSNYVTGKKSN Y155
Y281-p
DSSQPGLyTVSLyTK
0 1
TEC (human) DSSQPGLyTVSLyTK Y281-p
TEC (mouse) DSSQPGLYTVSLYTK Y280
TEC (rat) DSSQPGLYTVSLYTK Y203
Y286-p
GLyTVSLyTKFGGEG
0 1
TEC (human) GLyTVSLyTKFGGEG Y286-p
TEC (mouse) GLYTVSLYTKFGGEG Y285
TEC (rat) GLYTVSLYTKFGGEG Y208
S308-p
HIKETTTsPKKYYLA
0 2
TEC (human) HIKETTTsPKKYYLA S308-p
TEC (mouse) HIKETATSPKkYYLA S307
TEC (rat) HIKETATSPKKYYLA S230
K311
ETTTsPKKYYLAEKH
0 1
TEC (human) ETTTsPKKYYLAEKH K311
TEC (mouse) ETATSPKkYYLAEKH K310-ac
TEC (rat) ETATSPKKYYLAKKH K233
Y343-p
GLVTRLRyPVSVKGK
0 1
TEC (human) GLVTRLRyPVSVKGK Y343-p
TEC (mouse) GLVTRLRYPVSTKGK Y342
TEC (rat) GLVTRLRYPVSTKGK Y265
Y360-p
PTTAGFSyEKWEINP
0 1
TEC (human) PTTAGFSyEKWEINP Y360-p
TEC (mouse) PTTAGFSYDKWEINP Y359
TEC (rat) PTTAGFSYDKWEINP Y282
S378-p
TFMRELGsGLFGVVR
0 1
TEC (human) TFMRELGsGLFGVVR S378-p
TEC (mouse) TFMRELGSGLFGVVR S377
TEC (rat) TFMRELGSGLFGVVR S300
Y519-p
RYVLDDQytSSSGAk
Upstream
Downstream
1 342
Effects on Modified Protein
  • enzymatic activity, induced
Treatment
  • anti-CD3
  • FGF2
  • LPA
  • MG132_withdrawal
TEC (human) RYVLDDQytSSSGAk Y519-p
TEC (mouse) RYVLDDQytSSSGAK Y518-p
TEC (rat) RYVLDDQyTSSSGAK Y441-p
T520-p
YVLDDQytSSSGAkF
0 5
TEC (human) YVLDDQytSSSGAkF T520-p
TEC (mouse) YVLDDQytSSSGAKF T519-p
TEC (rat) YVLDDQyTSSSGAKF T442
K526-ub
ytSSSGAkFPVKWCP
0 1
TEC (human) ytSSSGAkFPVKWCP K526-ub
TEC (mouse) ytSSSGAKFPVKWCP K525
TEC (rat) yTSSSGAKFPVKWCP K448
Y572
PFEKYTNYEVVTMVT
0 1
TEC (human) PFEKYTNYEVVTMVT Y572
TEC (mouse) PFEKNTNyEVVTMVT Y571-p
TEC (rat) PFEKNTNYEVVTMVT Y494
T618-p
SFEDLLRtIDELVEC
0 1
TEC (human) SFEDLLRtIDELVEC T618-p
TEC (mouse) SLEDLLRTIDELVEC T617
TEC (rat) SFEDLLRTIDELVEC T540